BALANCE LABS, INC. |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.23 USD | -8.00% |
|
-.--% | -2.13% |
| 05-10 | Balance Labs, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
| 04-15 | Balance Labs, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Valuation
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Capitalization 1 | 29.19 | 16.26 | 7.152 | 15.61 | 5.093 | 5.093 |
| Enterprise Value (EV) 1 | 30.66 | 18.12 | 9.269 | 17.82 | 7.168 | 7.343 |
| P/E ratio | -53.3 x | -18.3 x | 20 x | -18 x | -5.88 x | -11.8 x |
| Yield | - | - | - | - | - | - |
| Capitalization / Revenue | 4,378 x | 4,877 x | 7.15 x | 25 x | 20.6 x | - |
| EV / Revenue | 4,599 x | 5,436 x | 9.27 x | 28.5 x | 29 x | - |
| EV / EBITDA | -51.1 x | -32.5 x | 15.1 x | 79.4 x | -315 x | - |
| EV / FCF | -170 x | -267 x | -31.9 x | 363 x | 40.5 x | 1,398 x |
| FCF Yield | -0.59% | -0.37% | -3.14% | 0.28% | 2.47% | 0.07% |
| Price to Book | -14.1 x | -5.62 x | -2.82 x | -4.69 x | -1.22 x | -1.12 x |
| Nbr of stocks (in thousands) | 21,620 | 21,674 | 21,674 | 21,674 | 21,674 | 21,674 |
| Reference price 2 | 1.350 | 0.7500 | 0.3300 | 0.7200 | 0.2350 | 0.2350 |
| Announcement Date | 01/04/19 | 28/05/20 | 31/03/21 | 31/03/22 | 17/04/23 | 15/04/24 |
1USD in Million2USD
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Net sales 1 | 0.006667 | 0.003333 | 1 | 0.6246 | 0.2475 | - |
| EBITDA 1 | -0.5995 | -0.557 | 0.6127 | 0.2245 | -0.0228 | - |
| EBIT 1 | -0.6031 | -0.5579 | 0.6125 | 0.2244 | -0.0228 | -0.1163 |
| Operating Margin | -9,045.37% | -16,739.93% | 61.25% | 35.93% | -9.23% | - |
| Earnings before Tax (EBT) 1 | -0.593 | -0.8899 | 0.3507 | -0.8094 | -0.7684 | -0.3816 |
| Net income 1 | -0.5477 | -0.8842 | 0.3578 | -0.7967 | -0.7684 | -0.3816 |
| Net margin | -8,214.76% | -26,529.16% | 35.78% | -127.56% | -310.44% | - |
| EPS 2 | -0.0253 | -0.0409 | 0.0165 | -0.0400 | -0.0400 | -0.0200 |
| Free Cash Flow 1 | -0.1809 | -0.0678 | -0.291 | 0.0491 | 0.177 | 0.005251 |
| FCF margin | -2,712.93% | -2,034.83% | -29.1% | 7.86% | 71.51% | - |
| FCF Conversion (EBITDA) | - | - | - | 21.88% | - | - |
| FCF Conversion (Net income) | - | - | - | - | - | - |
| Dividend per Share | - | - | - | - | - | - |
| Announcement Date | 01/04/19 | 28/05/20 | 31/03/21 | 31/03/22 | 17/04/23 | 15/04/24 |
1USD in Million2USD
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Net Debt 1 | 1.48 | 1.86 | 2.12 | 2.22 | 2.07 | 2.25 |
| Net Cash position 1 | - | - | - | - | - | - |
| Leverage (Debt/EBITDA) | -2.461 x | -3.345 x | 3.454 x | 9.872 x | -91.17 x | - |
| Free Cash Flow 1 | -0.18 | -0.07 | -0.29 | 0.05 | 0.18 | 0.01 |
| ROE (net income / shareholders' equity) | 32.6% | 35.2% | -12.7% | 27.1% | 20.3% | 8.77% |
| ROA (Net income/ Total Assets) | -173% | -126% | 50.8% | 12.3% | -1.98% | -22.4% |
| Assets 1 | 0.317 | 0.7002 | 0.7046 | -6.489 | 38.86 | 1.706 |
| Book Value Per Share 2 | -0.1000 | -0.1300 | -0.1200 | -0.1500 | -0.1900 | -0.2100 |
| Cash Flow per Share 2 | 0 | 0 | 0 | 0.0100 | 0.0100 | 0.0100 |
| Capex 1 | 0 | - | - | - | - | - |
| Capex / Sales | 62.58% | - | - | - | - | - |
| Announcement Date | 01/04/19 | 28/05/20 | 31/03/21 | 31/03/22 | 17/04/23 | 15/04/24 |
1USD in Million2USD
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
| 1st Jan change | Capi. | |
|---|---|---|
| -2.13% | 4.99M | |
| +12.27% | 7.81B | |
| -33.29% | 3.26B | |
| +10.62% | 2.77B | |
| -0.18% | 1.55B | |
| -9.84% | 1.06B | |
| +23.26% | 869M | |
| -8.89% | 717M | |
| -4.50% | 600M | |
| -19.75% | 533M |
- Stock Market
- Equities
- BLNC Stock
- Financials Balance Labs, Inc.
